InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Bailey John E. (Jack) Jr., Chief Executive Officer. Officer active across 1 companies, notably G1 Therapeutics, Inc.. Cumulatively, 2 reports have been logged. The latest transaction was filed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
046,000 shares0
Common Stock
SEC:0001562180-22-000302·
046,000 shares0
Common Stock
SEC:0001562180-22-000302:0·
2 of 2 declarations
About Bailey John E. (Jack) Jr.
John E. Bailey Jr. serves as President and CEO of G1 Therapeutics, Inc. In this role, he oversees the company's operations and is responsible for the overall strategy. His experience in the biopharmaceutical sector and commitment to innovation are valuable assets for G1 Therapeutics. He is dedicated to promoting research and the development of new therapies.
